SEC Form D · Amendment · filed January 12, 2022
IVIEW Therapeutics, Inc
Rule 506(b): private placement to accredited investors, no public advertising.
People & firms on this filing (20)
Xiaolu T. Sun · Cranbury, NJDirectorBo Liang · Cranbury, NJExec · DirectorJohn J. Baldwin · Cranbury, NJDirectorWei Wang · Cranbury, NJExec · DirectorQi Zhu · Cranbury, NJExec · DirectorBin T. He · Cranbury, NJDirectorMatthew Bailey · Vancouver, British Columbia, CanadaDirectorSheri Rempel · Vancouver, British Columbia, CanadaDirectorDavid Meltzer · Vancouver, British Columbia, CanadaDirectorKatrina Palanca · Vancouver, British Columbia, CanadaExec · DirectorCarey Dillen · Vancouver, British Columbia, CanadaExec · DirectorShafin Tejani · Vancouver, British Columbia, CanadaExec · DirectorTao J. Du · Doylestown, PADirectorJoseph S. Saffire · SALT LAKE CITY, UTDirectorGary S. Crittenden · SALT LAKE CITY, UTExec · DirectorJoseph S. Bonner · SALT LAKE CITY, UTExec · DirectorDiane S. Olmstead · SALT LAKE CITY, UTExec · DirectorSpencer S. Kirk · SALT LAKE CITY, UTDirectorMichael S. Rainen · Englewood, CODirectorTao J. Du · Doylestown, PADirector Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗